Laminin immunostaining and subsequent assessment of myofiber cross-sectional area (CSA) revealed a significant decrease in CSA in tumor-bearing mice in both age cohorts (young, P = 0.0003; aged, P = 0.03). The gene discussed is LAMB2; the disease is neoplasm.